Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 2B subunit epsilon (eIF2Bε) is the catalytic subunit of eIF2B, a multi-subunit enzyme complex that acts as a guanine nucleotide exchange factor for eukaryotic initiation factor 2 (eIF2), a key GTPase in protein translation initiation[1][2][5]. eIF2Bε, encoded by the *EIF2B5* gene, facilitates the exchange of GDP for GTP on eIF2, regulating protein synthesis rates in response to cellular conditions[4][6]. The complex is critical for modulating the integrated stress response (ISR), as its inactivation under stress conditions represses general translation but enhances selective expression of stress-response proteins[2]. Mutations in the *EIF2B5* gene are causative for leukoencephalopathy with vanishing white matter, a progressive neurodegenerative disorder[4]. The eIF2B complex, particularly its epsilon subunit, is considered a potential therapeutic target for modulating protein synthesis in neurodegenerative diseases and other ISR-related pathologies[2][6].
Inhibition (by phosphorylated eIF2α or by ISR-targeting compounds); Activation (by GTP recycling promotion on eIF2)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 2B subunit epsilon (eIF2Bε).